What's in Hevert-Arzneimittel GmbH & Co. KG's pipeline?

Hevert-Arzneimittel GmbH & Co. KG has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Hevert-Arzneimittel GmbH & Co. KG's portfolio?

Top competitors by shared drug class: Biologische Heilmittel Heel GmbH, Charite University, Berlin, Germany.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/hevert-arzneimittel-gmbh-co-kg.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Hevert-Arzneimittel GmbH & Co. KG — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hevert-Arzneimittel GmbH & Co. KG pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Placebo for Sinusitis Hevert SL Tablet	Placebo for Sinusitis Hevert SL Tablet	marketed			Otolaryngology / Rhinology
Sinusitis Hevert SL Tablet	Sinusitis Hevert SL Tablet	marketed	Homeopathic combination remedy		Otolaryngology / Respiratory

Therapeutic area mix

Otolaryngology / Respiratory · 1
Otolaryngology / Rhinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biologische Heilmittel Heel GmbH · 1 shared drug class
Charite University, Berlin, Germany · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Hevert-Arzneimittel GmbH & Co. KG:

Cite this brief

Drug Landscape (2026). Hevert-Arzneimittel GmbH & Co. KG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/hevert-arzneimittel-gmbh-co-kg. Accessed 2026-05-17.